CSL Limited (CMXHF) Financials
CMXHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 37.2 billion | 18.1 billion |
| June 30, 2023 | 36.2 billion | 18.4 billion |
| March 31, 2023 | ? | ? |
| Dec. 31, 2022 | 35.6 billion | 17.7 billion |
CMXHF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | 382.9 million | ? |
| June 30, 2023 | 779.4 million | ? |
| March 31, 2023 | ? | ? |
| Dec. 31, 2022 | 119.4 million | ? |
CMXHF Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2023 | 2.0 billion |
| June 30, 2023 | 595.3 million |
| March 31, 2023 | 285.4 million |
| Dec. 31, 2022 | 1.7 billion |
CMXHF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 1.0 billion | - | - |
| June 30, 2023 | 1.5 billion | - | 1.7 billion |
| March 31, 2023 | - | - | - |
| Dec. 31, 2022 | 1.5 billion | - | - |
CMXHF Shares Outstanding
CMXHF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 732.5 million | 699.1 million | - | - |
| June 30, 2023 | 809.9 million | 649.2 million | - | - |
| March 31, 2023 | 329.1 million | - | - | - |
| Dec. 31, 2022 | 878.0 million | 586.5 million | - | - |
CMXHF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 8.4 billion | 4.1 billion |
| June 30, 2023 | 5.9 billion | 3.3 billion |
| March 31, 2023 | - | - |
| Dec. 31, 2022 | 7.3 billion | 3.5 billion |
CMXHF
Price: $65.14
Dividend Yield: 3.20%
Forward Dividend Yield: 7.98%
Payout Ratio: 43.59%
Dividend Per Share: 5.20 USD
Earnings Per Share: 6.17 USD
P/E Ratio: 17.20
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Market Capitalization: 44.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 33
DGR3: 30.00%
DGR5: 29.51%
DGR10: 21.74%
DGR20: 20.17%